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SurvivalBackground: Histopathological grading of adenoid cystic carcinoma (ACC) is a controversial issue. It is
generally agreed that solid type ACC has a relatively poor prognosis. However, the amount of solid regions
within this often mixed type tumor that predicts a poor prognosis is not ﬁrmly established. Some authors
stipulate that the presence of a solid component regardless of the amount is a poor prognosticator where
others argue that the amount should be taken into consideration. Two grading systems most commonly
used are those described by Perzin et al./Szanto et al. and Spiro et al., respectively. They report that prog-
nosis of ACC is poor if >30% and >50% of the tumor volume has a solid growth pattern, respectively.
Material and methods: The described grading systems are applied to a series of 81 surgically treated cases
of ACC at the VU University Medical Center, Amsterdam, The Netherlands. Moreover, we introduced an
alternative grading system, in which the presence of a solid component, irrespective of its amount, is con-
sidered. All three systems of grading were tested for inter-observer concordance and prediction of prog-
nosis.
Results: Inter-observer concordance for grading ACC according to Perzin et al./Szanto et al. and Spiro
et al., proved to be moderate with Kappa Scores of 0.393 and 0.433, respectively. Our alternative grading
system yielded inter-observer concordance with a Cohen’s kappa result of 0.990. All systems were com-
parable in discriminating patients with poor clinical outcome. Histopathological grade proved to be an
independent prognosticator.
Conclusion: The presence of any solid component in ACC is a negative prognosticator, and can histopatho-
logically be diagnosed with a high reliability. These results suggest to merely register the presence or
absence of a solid tumor component since its inter-observer variability is very low, its reproducibility
is high and its predictive value is comparable to the traditional grading systems used.
 2014 Elsevier Ltd. All rights reserved.Introduction
Adenoid cystic carcinoma (ACC) of the head and neck is one of
the most prevalent malignant salivary gland neoplasms [1]. ACC
in general has a protracted course. It is notorious for its poor dis-
ease free survival due to frequent local recurrences and – often
indolent – distant metastases. The treatment of choice is surgery,
when feasible followed by radiotherapy (RT).Regarding its histological features ACC predominantly presents
as a mixed tumor, consisting of tubular, cribriform and/or solid
growth patterns. The tumor is mostly classiﬁed according to the
predominant pattern; the solid subtype is considered a high grade
tumor with poor prognosis, ﬁrst recognized as such in 1958 by
Patey and Thackray [2].
Compared to cribriform and tubular types, solid type ACC shows
a high percentage of loss of heterozygosity (LOH), more chromo-
somal aberrations and somatic mutations and a high expression
of p53 [3–8]. Some authors speculate that the risk of nodal metas-
tases is higher when solid ACC is present [9].
For ACC, two different histopathological grading systems are
currently used. These are one grading system described by Perzin
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refer to these grading systems as Perzin/Szanto and Spiro, resp.
Both grading systems can discriminate patients with a poor prog-
nosis, based upon the amount of solid component present in the
tumor. In the Perzin/Szanto system, ACC is considered high grade
if more than 30% of the tumor consists of a solid component. In
the Spiro system, more than 50% of solid parts are considered high
grade. In these grading systems, the amount of tumor to be inves-
tigated is not (clearly) deﬁned [10–12].
Next to these established schemes, we studied the usefulness of
a new histopathological grading system scoring the mere presence
of solid type ACC in the histological specimen, irrespective of its
amount. The main goal was to provide a reliable grading system
with good reproducibility and with a low inter-observer variability,
which are prerequisites for a practical grading system. Further-
more, the importance of histopathological grading relative to other
known prognosticators such as T-stage and N-status is
investigated.Fig. 1. (A) Cribriform, (B) tubular and (C) solid type ACC.Materials and methods
One-hundred and ﬁve patients with ACC attended our institu-
tion for treatment between 1979 and 2009, and of these, 87
patients were treated surgically. During this period, treatment
strategies remained unchanged.
Of these 87 patients, H&E stained slides were available for
review in 81 cases which were included in this study. All available
slides – almost always plural per case – were revised and graded
independently by two expert head and neck pathologists (EB and
IVDW). In case of discordant grading an agreement was reached.
Grading was carried out according to the currently used systems
by Perzin/Szanto and Spiro, respectively [10–12]. The deﬁnitions
of these grading systems are shown in Table 1. The histopatholo-
gical criteria of this predominantly mixed type tumor were scored
according to the criteria of the World Health Organization (WHO)
[1]. The three types of ACC are shown in Fig. 1.
For analysis, specimens were subdivided in low and high grade
ACC. This was done according to the deﬁnitions in the original
papers [10–12]. According to these deﬁnitions, low grade ACC con-
sists of Perzin/Szanto grade I (predominantly tubular, no solid) and
II (predominantly cribriform, <30% solid) and Spiro grade I (mostly
tubular/cribriform, occasional solid). High grade ACC thus consists
of Perzin/Szanto grade III (>30% solid component) and Spiro grade
II (substantial solid; >50%) and III (only solid).
An additional scoring system was introduced which reported
the presence or absence of solid type ACC in the specimen, regard-
less of the amount or further composition of this predominantly
mixed type tumor. We considered this a new grading system,
deﬁned as Solid± (S±).
A Cohen’s kappa test was performed to analyse inter-observer
variability for the different grading systems. The Cohen’s kappaTable 1
Deﬁnitions of grading systems as used in current literature and the S± system.
Perzin/Szanto [10,11] Spiro et al. [12] Present
study
Grade Grade Solid/no
solid
I. Predominantly tubular, no
solid
I. Mostly tubular or cribriform,
occasional solid
S+
II. Predominantly cribriform,
<30% solid
II. Mixed with substantial solid
(>50%)
S
III. Solid component > 30% III. Only Solidtest is a reliable and often used test for measuring inter-observer
variability with values ranging from 0 to 1.00, where values of
>0.70 are considered satisfactory [13].
Possible additional prognostic factors registered were TNM
stage (retrospectively staged according to UICC, 7th edition) [14],
treatment modalities, perineural invasion (deﬁned as extension
of epithelial tumor cells around nerves), metastases, microscopic
margins, type of salivary gland involved, gender and age. Uni-
and multivariate survival analyses were performed using the Log
rank and Cox regression test with SPSS statistical software version
15.0 (IBM, New York, USA). The different survival parameters
scored were local control rate (LCR), distant disease free survival
(DDFS), disease free survival (DFS), disease speciﬁc survival (DSS)
overall survival (OS) and hazard ratios (HR) with conﬁdence inter-
vals (CI).
A Harrell’s concordance index (C-index) – a test for assessing
prediction performance in survival analyses – was calculated to
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vival [15].
Results
One hundred and ﬁve cases of previously untreated ACC were
identiﬁed, of which 87 underwent surgery with curative intent, fol-
lowed by radiotherapy in the majority of cases (93%). Patients’ age
ranged from 19 to 87 year (mean 57.3 year). Of the 87 surgically
treated cases, 81 histological specimens were available for review.
Forty-one patients were female (51%) and 41 cases involved the
major salivary glands (51%). The demographic, tumor and treat-
ment characteristics are shown in Table 2. 35/81 (43%) specimens
contained solid type ACC regardless of the amount.
Application of the grading systems according to Perzin/Szanto
and Spiro resp. by two expert pathologists showed that the desig-
nation of grade in 50/81 (62%) tumors differed, solely on the basis
of the different criteria in the two grading systems. This is due to
the deﬁned cut off point for the relative amount of solid tumor
(30% vs. 50%, respectively). This sometimes even led to a two grade
difference (i.e. a mixed tumor with >30% and <50% solid compo-
nent is Perzin/Szanto grade III and Spiro grade I). Moreover, a
Cohen’s kappa test was done to analyse the inter-observer variabil-
ity of the different grading systems based on the original grading.
Results showed values of 0.393 (fair) for Perzin/Szanto, 0.433
(moderate) for Spiro and 0.990 (almost perfect) for S±.
In order to actually determine the true clinical relevance of
grading as such, both a univariate and a multivariate analysis wereTable 2
Clinicopathological data of 81 reviewed cases of ACC.
Gender
Male 40 (49%)
Female 41 (51%)
Age 19–87 year (mean 57.3 year)
Major/Minor
Major 41 (51%)
Minor 40 (49%)
Histology/Grade Perzin/Szanto Spiro
I 19 (23%) 58 (72%)
II 40 (49%) 12 (15%)
III 22 (27%) 11 (14%)
Solid
Yes 45 (56%)
No 36 (44%)
UICCa-stage
I 20 (25%)
II 25 (30%)
III 8 (10%)
IV 28 (35%)
N-stage
N1 2 (2%)
N2a 1 (1%)
N2b 4 (5%)
N2c 2 (2%)
N3 0
Perineural invasion
Yes 63 (78%)
No 14 (17%)
NRb 4 (5%)
Surgical margins
P5 mm 10 (12%)
1 < 5 mm 9 (11%)
<1 mm 62 (77%)
Postoperative RT
Yes 75 (93%)
No 6 (7%)
a Union for international cancer control.
b Not reported.done. Univariate analysis showed that LCR, DDFS, DFS, DSS and OS
all were signiﬁcantly related (p-range <0.001–0.011) to tumor
grade, irrespective of the grading system used, and to stage. Multi-
variate analysis for DSS with stepwise implementing of the prog-
nostic factors T-stage and N-status was performed separately for
the three grading systems. Table 3 shows a comparable outcome
for all three grading systems.
In 10 cases (11%), positive lymph nodes were found at ﬁrst pre-
sentation. In 9 out of these 10 cases pathology specimens were
available for revision and showed high grade tumor in 6/9 patients
(67%) and presence of solid type tumor in 8/9 cases (89%).
The 5, 10 and 20-year DSS and OS rates for the different grad-
ing systems (Perzin/Szanto, Spiro and S±) are shown in Table 4.
Fig. 2 show the Kaplan Meier curves for DSS for a maximum fol-
low up of 20 years for Perzin/Szanto, Spiro and S±, respectively.
The results all show high signiﬁcance with a poor survival for
high grade (Perzin/Szanto grade III, Spiro grade II and III and
S+) tumors. DSS and OS are also related to tumor stage (data
not shown). Since it is generally assumed that stage is the stron-
gest prognosticator for ACC [16], effects of stage on survival in
low and high grade tumors is shown separately (Figs. 3A–3D).
Finally, a Harrell’s C-index was calculated to evaluate the actual
predictive power of the grading systems used in this study. This
shows that all three grading systems have a comparable predic-
tive strength (Table 5).Discussion
The debate on the role and actual importance of histopatholo-
gical grading of ACC has been on-going for some decades. Some
authors advocate that ACC should be predominantly solid to be
of inﬂuence on outcome where others stipulate that the presence
of a solid pattern regardless of its quantity encompasses a high
grade tumor [17–22]. The results of the present study concur with
the latter.
One could argue that its importance is limited, for treatment
strategies – surgery ± RT – remain unchanged so it bears no clinical
consequence. On the other hand, the quest for identifying adjuvant
treatment targets for ACC has been disappointing so far. Grading
based upon the presence of solid growth pattern seems to be an
independent prognosticator according to the present study and
should be taken into account as such, as is the case for T-stage
and N-status, thus providing the clinician and the patient with
additional prognostic information.
Although the deﬁnition of the currently used grading systems is
rather different, they are both used. Difﬁculty is however encoun-
tered using these systems [17]. For both grading systems used, the
deﬁned cut-off point is difﬁcult to calculate and prone to error.
These could be reasons that tumor stage is considered more indic-
ative for prognosis than grade – as reported by Spiro et al. – and
that histology is often described according to the predominant pat-
tern rather than as a numeric grade [16].
In the present study, all but one case with lymph node metasta-
ses contained solid type tumor, supporting the assertion by Myers
et al. that there is a higher likelihood of lymph node metastases in
solid type ACC [9]. Besides the histological subtype, recent reports
emphasize the possible importance of the proliferative marker Ki-
67, where a high index correlates with poorer outcome [23,24].
We suggest to exclude or conﬁrm the mere presence of a solid
component and to report it as such through the S± grading system.
The Cohen’s kappa test – a proven reliable measure for inter obser-
ver variability – shows a slightly better outcome for Spiro com-
pared to Perzin/Szanto which is in accordance with the study by
Therkildsen et al. [14,25,26]. However, both results show only fair
to moderate values for inter-observer variability. The S± grading
Table 3
Multivariate analysis (cox regression) with hazard ratio’s (HR) and 95% conﬁdence intervals (CI) for 81 histologically reviewed cases. Separate analysis for Perzin/Szanto, Spiro and
S±.
HR 95% CI HR 95% CI HR 95% CI
Perzin/Szanto Spiro Solid
I 1.0 I 1.0 No 1.0
II 1.7 0.6–4.4 II 3.6 1.6–8.2 Yes 3.9 1.7–9.1
III 5.7 2.2–15.2 III 6.2 2.5–15.3
T-stage
1 1.0 1.0 1.0
2 12.3 1.6–95.0 13.1 1.6–102.0 5.7 0.7–44.9
3 24.8 2.8–219.0 25.6 2.9–227.7 9.9 1.1–85.5
4 26.7 3.4–206.8 29.3 3.7–230.2 13.3 1.7–103.6
N-status
N0 1.0 1.0 1.0
N+ 4.1 1.7–9.7 4.1 1.7–10.0 5.1 2.0–12.8
Table 4
Five, ten and twenty-year disease speciﬁc-and overall survival for Perzin/Szanto, Spiro and Solid±.
Perzin/Szanto (p < 0.001) Spiro (p < 0.001) S± (p < 0.001)
I II III I II III No Yes
5 year DSSa (%) 90 75 36 82 39 27 90 53
5 year OSb (%) 90 75 36 82 39 27 90 53
10 year DSS (%) 73 60 22 66 26 13 73 37
10 year OS (%) 73 55 22 62 26 13 70 34
20 year DSS (%) 58 48 11 52 0 0 64 26
20 year OS (%) 50 20 11 35 0 0 45 19
a Disease speciﬁc survival.
b Overall survival.
Fig. 2A. DSS for grading according to Szanto (Log Rank, signiﬁcance p < 0.05). Fig. 2B. DSS for grading according to Spiro (Log Rank, signiﬁcance p < 0.05).
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resulted in an excellent correlation.
The Harrell’s C-index shows that the predictive power of this
grading system is equal to that of the other two grading systems.
In previous studies, contradictory results are reported on the clin-
ical relevance of grading [24,27]. However, the present study con-
ﬁrms through multivariate analysis that grade is an independent
prognosticator which is in accordance with the study from da Cruz
Perez et al. who report somewhat the same HR for solid type ACC
(3.9 vs. 3.6, respectively) [27]. According to the results in this
study, it is rather questionable to describe ACC histology according
to its predominant pattern for the mere presence of solid typetumor despite predominance of another subtype seems to be of
signiﬁcant inﬂuence on survival.
According to the present study, high T-stage and N+-status
remain the most powerful negative prognosticators. Because of
the reliability, reproducibility and predictive power of the S± grad-
ing system we regard this grading system as a meaningful adjunct
to the currently used grading systems, for grade has a signiﬁcant
impact on survival [11,12,24,27,28].
Conﬂict of interest statement
None declared.
Fig. 2C. DSS for grading according to S± (Log Rank, signiﬁcance p < 0.05).
Fig. 3A. DSS for low grade ACC subdivided for early (I–II) and advanced stage (III–
IV) disease (Log Rank, signiﬁcance p < 0.05).
Fig. 3B. DSS for high grade ACC subdivided for early (I–II) and advanced stage (III–
IV) disease (Log Rank, signiﬁcance p < 0.05).
Fig. 3C. DSS for non-solid ACC subdivided for early (I–II) and advanced stage (III–IV)
disease (Log Rank, signiﬁcance p < 0.05).
Fig. 3D. DSS for solid ACC subdivided for early (I–II) and advanced stage (III–IV)
disease (Log Rank, signiﬁcance p < 0.05).
Table 5
Harrell’s C-index (H C) for all three grading systems.
Perzin/Szanto Spiro S±
H C 95% CI H C 95% CI H C 95% CI
LCRa 0.62 0.52–0.72 0.63 0.55–0.71 0.61 0.51–0.70
DDFSb 0.64 0.56–0.73 0.63 0.56–0.70 0.62 0.54–0.70
DFSc 0.64 0.56–0.72 0.63 0.57–0.69 0.60 0.52–0.67
DSSd 0.66 0.58–0.74 0.65 0.59–0.72 0.65 0.57–0.73
OSe 0.66 0.58–0.73 0.64 0.58–0.70 0.64 0.57–0.71
a Local control rate.
b Distant disease free survival.
c Disease free survival.
d Disease speciﬁc survival.
e Overall survival.
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